Deadline for application: 16 July 2014
Job summary
Location: Brussels
Further details
Web address for further details
http://www.imi.europa.eu/content/jobs
IMI is seeking to recruit a new Executive Director as the non-renewable mandate for the current holder of the post, Professor Michel Goldman, ends in December 2014.
Location: Brussels
Further details
The Innovative Medicines Initiative Joint Undertaking (IMI JU) is a public-private partnership between the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The objective of the IMI Joint Undertaking is to improve the efficiency and effectiveness of the drug development process with the long-term aim that the pharmaceutical sector produces more effective and safer innovative medicines.
The successful candidate should take up his/her duties on 1 January 2015. The new Executive Director will be expected to manage IMI to the highest standards and to ensure the continued success of the initiative, which will enter into a second phase in July this year.
The Executive Director is the legal representative and public face of the IMI Joint Undertaking. He/she shall perform his/her tasks with independence and shall be accountable to the Governing Board.
The Executive Director will provide leadership for the Joint Undertaking at the strategic and operational level. He/she will manage the Joint Undertaking and take overall responsibility for its operations ensuring the achievement of the Joint Undertaking's objectives. As such, he/she will play a key role for the implementation of the IMI Joint Technology Initiative. Furthermore the Executive Director will actively participate in the international discourse about the funding for life science and biopharmaceutical research.
The objective of the IMI Joint Undertaking is to improve the efficiency and effectiveness of the drug development process with the long-term aim that the pharmaceutical sector produces more effective and safer innovative medicines.
The successful candidate should take up his/her duties on 1 January 2015. The new Executive Director will be expected to manage IMI to the highest standards and to ensure the continued success of the initiative, which will enter into a second phase in July this year.
The Executive Director is the legal representative and public face of the IMI Joint Undertaking. He/she shall perform his/her tasks with independence and shall be accountable to the Governing Board.
The Executive Director will provide leadership for the Joint Undertaking at the strategic and operational level. He/she will manage the Joint Undertaking and take overall responsibility for its operations ensuring the achievement of the Joint Undertaking's objectives. As such, he/she will play a key role for the implementation of the IMI Joint Technology Initiative. Furthermore the Executive Director will actively participate in the international discourse about the funding for life science and biopharmaceutical research.
Web address for further details
http://www.imi.europa.eu/content/jobs
Posts
0 comments:
Post a Comment